CTP-amio(Vivasc Therapeutics)

N/A

Report date: 2024/09/02 17:46:25
NME

Base Information

Drug NameCTP-amio(Vivasc Therapeutics)
Drug Alias NameCTP-amio
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionKATP channels blockersBeta adrenergic receptors antagonistsSodium channels blockers
TargetsBeta adrenergic receptorsKATP channelsSodium channels
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of PittsburghVivasc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVivasc Therapeutics IncUniversity Of Pittsburgh
Inactive CompaniesN/A
Active IndicationsArrhythmias, Cardiac
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A